These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32011662)

  • 1. Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy.
    Finocchiaro G; Dhutia H; Gray B; Ensam B; Papatheodorou S; Miles C; Malhotra A; Fanton Z; Bulleros P; Homfray T; Witney AA; Bunce N; Anderson LJ; Ware JS; Sharma R; Tome M; Behr ER; Sheppard MN; Papadakis M; Sharma S
    Europace; 2020 Apr; 22(4):632-642. PubMed ID: 32011662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy in myosin-binding protein C (
    Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
    Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
    Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
    Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning.
    Captur G; Heywood WE; Coats C; Rosmini S; Patel V; Lopes LR; Collis R; Patel N; Syrris P; Bassett P; O'Brien B; Moon JC; Elliott PM; Mills K
    Mol Cell Proteomics; 2020 Jan; 19(1):114-127. PubMed ID: 31243064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in
    Salazar-Mendiguchía J; Ochoa JP; Palomino-Doza J; Domínguez F; Díez-López C; Akhtar M; Ramiro-León S; Clemente MM; Pérez-Cejas A; Robledo M; Gómez-Díaz I; Peña-Peña ML; Climent V; Salmerón-Martínez F; Hernández C; García-Granja PE; Mogollón MV; Cárdenas-Reyes I; Cicerchia M; García-Giustiniani D; Lamounier A; Gil-Fournier B; Díaz-Flores F; Salguero R; Santomé L; Syrris P; Olivé M; García-Pavía P; Ortiz-Genga M; Elliott PM; Monserrat L;
    Heart; 2020 Sep; 106(17):1342-1348. PubMed ID: 32451364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).
    Reader JR; Canfield DR; Lane JF; Kanthaswamy S; Ardeshir A; Allen AM; Tarara RP
    Comp Med; 2016 Apr; 66(2):162-9. PubMed ID: 27053572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: preclinical and early phenotype.
    Ho CY
    J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Profile of Athletes With Hypertrophic Cardiomyopathy.
    Sheikh N; Papadakis M; Schnell F; Panoulas V; Malhotra A; Wilson M; Carré F; Sharma S
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003454. PubMed ID: 26198026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.
    Maron BJ; Roberts WC; Arad M; Haas TS; Spirito P; Wright GB; Almquist AK; Baffa JM; Saul JP; Ho CY; Seidman J; Seidman CE
    JAMA; 2009 Mar; 301(12):1253-9. PubMed ID: 19318653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography.
    Joy G; Lopes LR; Webber M; Ardissino AM; Wilson J; Chan F; Pierce I; Hughes RK; Moschonas K; Shiwani H; Jamieson R; Velazquez PP; Vijayakumar R; Dall'Armellina E; Macfarlane PW; Manisty C; Kellman P; Davies RH; Tome M; Koncar V; Tao X; Guger C; Rudy Y; Hughes AD; Lambiase PD; Moon JC; Orini M; Captur G
    J Am Coll Cardiol; 2024 Mar; 83(11):1042-1055. PubMed ID: 38385929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
    Ho CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
    Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
    Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
    Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
    Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigorous exercise in patients with hypertrophic cardiomyopathy.
    Dejgaard LA; Haland TF; Lie OH; Ribe M; Bjune T; Leren IS; Berge KE; Edvardsen T; Haugaa KH
    Int J Cardiol; 2018 Jan; 250():157-163. PubMed ID: 29169752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study.
    Grover S; Lloyd R; Perry R; Lou PW; Haan E; Yeates L; Woodman R; Atherton JJ; Semsarian C; Selvanayagam JB
    Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):932-938. PubMed ID: 30668650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.